Eric M. Dube is CEO at Travere Therapeutics, Inc. (TVTX). They have made 19 open-market trades across 2 companies since 2020, most recently 2026-09-17.
CIK 0001763494
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 19 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| TVTX | 432,886 | $21.5M |
| RTRX | 96,260 | $2.3M |
| Total | $23.8M |
Shares reported on the most recent Form 4, priced at the 2026-09-17 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| TVTX | SELL · 10b5-1 | 2026-09-15 | 2026-09-17 | $63.48 | $25.4M | -7.0% | — | — |
| TVTX | SELL · 10b5-1 | 2026-05-06 | 2026-05-06 | $43.95 | $989K | -5.7% | +0.6% | +23.2% |
| TVTX | SELL · 10b5-1 | 2026-04-15 | 2026-04-15 | $41.09 | $2.6M | +2.5% | +6.9% | +43.3% |
| TVTX | SELL · 10b5-1 | 2026-04-01 | 2026-04-02 | $30.93 | $1.9M | +33.5% | +46.5% | +83.7% |
| TVTX | SELL · 10b5-1 | 2026-02-20 | 2026-02-24 | $30.10 | $1.8M | -11.7% | -9.5% | +43.4% |
| TVTX | SELL · 10b5-1 | 2026-02-03 | 2026-02-03 | $32.28 | $3.2M | -15.2% | -16.7% | +37.0% |
| TVTX | SELL | 2026-01-23 | 2026-01-27 | $30.09 | $1.8M | -0.6% | -0.6% | +36.5% |
| TVTX | SELL · 10b5-1 | 2025-10-28 | 2025-10-30 | $30.32 | $7.3M | +4.4% | +1.7% | -12.5% |
| TVTX | SELL · 10b5-1 | 2025-05-05 | 2025-05-05 | $21.05 | $797K | +0.7% | -27.6% | -24.0% |
| TVTX | SELL · 10b5-1 | 2025-02-11 | 2025-02-12 | $24.04 | $273K | -10.5% | -14.4% | -9.2% |
| TVTX | SELL · 10b5-1 | 2025-02-03 | 2025-02-04 | $20.21 | $2.0M | +8.8% | -10.1% | +1.7% |
| TVTX | SELL · 10b5-1 | 2025-01-22 | 2025-01-23 | $19.46 | $418K | +0.7% | +1.3% | -20.3% |
| TVTX | SELL · 10b5-1 | 2024-09-09 | 2024-09-09 | $11.52 | $243K | +16.7% | +36.4% | +45.5% |
| TVTX | SELL | 2024-02-01 | 2024-02-02 | $8.70 | $333K | -0.8% | -1.6% | -26.0% |
| TVTX | SELL | 2024-01-23 | 2024-01-25 | $8.96 | $141K | -5.5% | -12.5% | -40.6% |
| TVTX | SELL | 2023-09-05 | 2023-09-05 | $14.71 | $131K | -4.1% | -44.7% | -56.0% |
| TVTX | SELL | 2023-02-01 | 2023-02-02 | $22.25 | $182K | -7.8% | +0.7% | -28.0% |
| TVTX | SELL | 2023-01-24 | 2023-01-26 | $21.50 | $139K | -0.2% | -0.5% | -5.6% |
| TVTX | SELL | 2023-01-05 | 2023-01-06 | $20.75 | $233K | +5.7% | +10.1% | +4.3% |
| TVTX | SELL | 2022-02-10 | 2022-02-11 | $27.84 | $269K | -2.9% | -15.0% | -23.3% |
| TVTX | SELL | 2022-01-31 | 2022-02-02 | $27.40 | $264K | +9.3% | +2.7% | +0.3% |
| TVTX | SELL | 2022-01-24 | 2022-01-26 | $24.98 | $393K | +4.5% | +0.8% | -0.4% |
| TVTX | SELL | 2022-01-04 | 2022-01-06 | $30.08 | $1.0M | -11.5% | -4.9% | -2.3% |
| TVTX | SELL | 2021-08-17 | 2021-08-17 | $17.12 | $268K | +9.6% | +14.3% | +49.6% |
| TVTX | SELL | 2021-06-01 | 2021-06-03 | $14.71 | $211K | +5.1% | +5.8% | +55.7% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.